Atjaunināt sīkdatņu piekrišanu

Integrated Molecular Medicine for Neuronal and Neoplastic Disorders, Volume 1086 [Mīkstie vāki]

Edited by (Nagoya University Graduate School of Medicine), Edited by , Edited by , Edited by , Edited by (Nagoya University Graduate School of Medicine), Edited by (Nagoya University Graduate School of Medicine)
  • Formāts: Paperback / softback, 200 pages, height x width x depth: 230x154x10 mm, weight: 417 g
  • Sērija : Annals of the New York Academy of Sciences
  • Izdošanas datums: 26-Jan-2007
  • Izdevniecība: Wiley-Blackwell
  • ISBN-10: 1573316555
  • ISBN-13: 9781573316552
Citas grāmatas par šo tēmu:
  • Mīkstie vāki
  • Cena: 133,72 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Paperback / softback, 200 pages, height x width x depth: 230x154x10 mm, weight: 417 g
  • Sērija : Annals of the New York Academy of Sciences
  • Izdošanas datums: 26-Jan-2007
  • Izdevniecība: Wiley-Blackwell
  • ISBN-10: 1573316555
  • ISBN-13: 9781573316552
Citas grāmatas par šo tēmu:
This text is derived from an international symposium held in Nagoya, Japan, in December 2005, on pathogenesis and therapy development for neurological and psychiatric disorders. Twenty contributions are organized into sections on motor neuron diseases, Alzheimer's disease and related neurodegenerative disorders, neuroprotective strategy for neurodegenerative diseases, neuronal polarity and psychiatric disorders, and novel targets for cancer therapy. A sampling of topics: gene expression profiling toward understanding of ALS pathogenesis, brain keratan sulfate and glial scar formation, molecular mechanisms of axon specification and neuronal disorders, and involvement of DPPIV/CD26 in epithelial morphology and suppressed invasive ability in ovarian carcinoma cells. No subject index. Annotation ©2007 Book News, Inc., Portland, OR (booknews.com)

Neurodegenerative disorders and malignant tumors are usually resistant to any treatment, and the mortality rate is very high for persons with these conditions. Accordingly, finding effective treatments for these diseases is one of the most serious issues for medicine in the 21st century.

In this volume, the molecular mechanisms of neurodegenerative disorders and malignant tumors are addressed, as are new therapeutic tools that exploit our understanding of these disease mechanisms. Substantial evidence for the existence of common molecular pathways for both neurodegeneration and tumor growth has been found, and many novel molecules related to both of them have also been discovered.

Because integrated research on neuronal and neoplastic disorders is singularly effective in overcoming these disorders, this volume will be an excellent source of information on the state of the research in this field and on the development of its applications in human disease therapy.

NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.

ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit www.nyas.org/membership/main.asp for more information about becoming a member.

Preface: Integrated Molecular Medicine for Neuronal and Neoplastic Disorders. xi
Gen Sobue
Masahide Takahashi
Jun Yoshida
Kozo Kaibuchi
Tomoki Naoe
Debomoy K. Lahiri
Part I. Motor Neuron Diseases
Gene Expression Profiling toward Understanding of ALS Pathogenesis.
1(10)
Fumiaki Tanaka
Jun-Ichi Niwa
Shinsuke Ishigaki
Masahisa Katsuno
Masahiro Waza
Masahiko Yamamoto
Manabu Doyu
Gen Sobue
Role of Polyunsaturated Fatty Acids for Misfolding Protein Aggregations: Implication for Neurodegenerative Diseases.
11(10)
Yeon-Jeong Kim
Ryosuke Takahashi
Alleviating Neurodegeneration by an Anticancer Agent: An Hsp90 Inhibitor (17-AAG).
21(14)
Masahiro Waza
Hiroaki Adachi
Masahisa Katsuno
Makoto Minamiyama
Fumiaki Tanaka
Gen Sobue
Part II. Alzheimer's Disease and Related Neurodegenerative Disorders
LRP in Amyloid-β Production and Metabolism.
35(19)
Guojun Bu
Judy Cam
Celina Zerbinatti
Neuronal Differentiation Is Accompanied by Increased Levels of SNAP-25 Protein in Fetal Rat Primary Cortical Neurons: Implications in Neuronal Plasticity and Alzheimer's Disease.
54(12)
Jason A. Bailey
Debomoy K. Lahiri
Myosin Va Mutation in Rats Is an Animal Model for the Human Hereditary Neurological Disease, Griscelli Syndrome Type 1.
66(15)
Yoshiko Takagishi
Yoshiharu Murata
Part III. Neuroprotective Strategy for Neurodegenerative Diseases
Brain Keratan Sulfate and Glial Scar Formation.
81(10)
Haoqian Zhang
Kenji Uchimura
Kenji Kadomatsu
The Direct and Indirect Effects of Serofendic Acid on Neuroprotection.
91(13)
Yukiko Doi
Jianfeng Liang
Reiko Kuno
Guiqin Zang
Jun Kawanokuchi
Izumi Yawata
Hideyuki Takeuchi
Tetsuya Mizuno
Akio Suzumura
Cytoplasmic Lipid Droplets: Rediscovery of an Old Structure as a Unique Platform.
104(12)
Toyoshi Fujimoto
Yuki Ohsaki
Part IV. Neuronal Polarity and Psychiatric Disorders
Molecular Mechanisms of Axon Specification and Neuronal Disorders.
116(10)
Takeshi Yoshimura
Nariko Arimura
Kozo Kaibuchi
Disrupted-in-Schizophrenia-1 (DISCI): A Key Susceptibility Factor for Major Mental Illnesses.
126(8)
Naoya Sawamura
Akira Sawa
Psychological, Neuroimaging, and Biochemical Studies on Functional Association between Impulsive Behavior and the 5-HT2A Receptor Gene Polymorphism in Humans.
134(10)
Michio Nomura
Yasuyuki Nomura
Investigating Gene-to-Behavior Pathways in Psychiatric Disorders: The Use of a Comprehensive Behavioral Test Battery on Genetically Engineered Mice.
144(16)
Keizo Takao
Tsuyoshi Miyakawa
Animal Model of Schizophrenia: Dysfunction of NMDA Receptor-Signaling in Mice following Withdrawal from Repeated Administration of Phencyclidine.
160(9)
Toshitaka Nabeshima
Akihiro Mouri
Rina Murai
Yukihiro Noda
Part V. Novel Targets for Cancer Therapy
Girdin, a Novel Action-Binding Protein, and Its Family of Proteins Possess Versatile Functions in the Akt and Wnt Signaling Pathways.
169(16)
Atsushi Enomoto
Jiang Ping
Masahide Takahashi
Biosignals Modulated by Tumor-Associated Carbohydrate Antigens: Novel Targets for Cancer Therapy.
185(14)
Koichi Furukawa
Kazunori Hamamura
Wei Aixinjueluo
Keiko Furukawa
FAK Signaling in Neoplastic Disorders: A Linkage between Inflammation and Cancer.
199(14)
Naing Naing Mon
Satoko Ito
Takeshi Senga
Michinari Hamaguchi
SFK-STAT Pathway: An Alternative and Important Way to Malignancies.
213(10)
Fumihiko Hayakawa
Tomoki Naoe
Pharmacogenetic Approach for Cancer Treatment--Tailored Medicine in Practice.
223(10)
Yoshinori Hasegawa
Yuichi Ando
Maki Ando
Naozumi Hashimoto
Kazuyoshi Imaizumi
Kaoru Shimokata
Involvement of DPPIV/CD26 in Epithelial Morphology and Suppressed Invasive Ability in Ovarian Carcinoma Cells.
233(8)
Hiroaki Kajiyama
Kiyosumi Shibata
Mikio Terauchi
Kazuhiko Ino
Akihiro Nawa
Fumitaka Kikkawa
Erratum 241(2)
Index of Contributors 243


Gen Sobue MD, PhD Professor, Department of Neurology, Nagoya University Graduate School of Medicine Specialized field - Neurology. He graduated in 1975 from Nagoya University School of Medicine and later worked at the Nagoya University Graduate School of Medicine.